18 AI News and Ratings Making Waves on Wall Street

Page 8 of 16

9. Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)

Number of Hedge Fund Holders: 25

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) provides nucleic acid and biologics safety testing products for drug development, diagnostics, and vaccine research.

On February 24, Maravai LifeSciences announced that it completed its acquisition of Officinae Bio’s DNA and RNA business, integrating AI-driven mRNA design technology with its TriLink BioTechnologies manufacturing capabilities. Officinae Bio’s digital platform improves the rapid prototyping of mRNA drug candidates, improving sequence optimization and clinical progression.

The acquisition marks Maravai’s entry into the European market with a manufacturing presence, supporting growth across different product lines. Officinae Bio’s CEO, Davide De Lucrezia, highlighted the benefits of combining AI-driven tools with TriLink’s manufacturing expertise.

Page 8 of 16